on Vitruvia Medical AG (isin : CH0461931419)
Vitruvia Medical AG Reports Half-Year Results for 2025
Vitruvia Medical AG has released its half-year financial results as of June 30, 2025. The company reports a net loss of CHF 73,889.88, a slight decline compared to the CHF 53,388.06 loss in the same period last year. Despite this, the Board of Directors maintains its forecast for the entire year.
Projected consolidated sales for the year are expected to reach approximately EUR 2.4 million. The company anticipates an improvement in earnings when compared to the previous year, aligning with the management's expectations for the first half of 2025.
Vitruvia Medical AG's management remains confident in its performance and outlook as the year progresses, aiming for a stronger financial standing overall.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Vitruvia Medical AG news